DIANA, ANNA
 Distribuzione geografica
Continente #
EU - Europa 174
AS - Asia 130
NA - Nord America 77
SA - Sud America 25
AF - Africa 1
Totale 407
Nazione #
RU - Federazione Russa 94
US - Stati Uniti d'America 74
SG - Singapore 44
CN - Cina 34
BR - Brasile 24
HK - Hong Kong 24
IE - Irlanda 24
IT - Italia 23
DE - Germania 20
KR - Corea 10
VN - Vietnam 6
FI - Finlandia 5
IN - India 5
CZ - Repubblica Ceca 3
JP - Giappone 3
NL - Olanda 2
PK - Pakistan 2
BE - Belgio 1
CA - Canada 1
GB - Regno Unito 1
HN - Honduras 1
ID - Indonesia 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
VE - Venezuela 1
Totale 407
Città #
Moscow 32
Dublin 24
Hong Kong 24
Singapore 23
Santa Clara 15
Hefei 12
Seoul 10
Munich 9
Naples 7
New York 7
Ashburn 6
Bengaluru 5
Chandler 5
Los Angeles 5
Nuremberg 5
Beijing 4
Boydton 4
Milan 4
Brno 3
Helsinki 3
São Paulo 3
Ho Chi Minh City 2
Orvieto 2
Somma Vesuviana 2
The Dalles 2
Amsterdam 1
Aracaju 1
Araponga 1
Atlanta 1
Aversa 1
Belo Horizonte 1
Boardman 1
Brasília 1
Bremen 1
Brussels 1
Bắc Ninh 1
Cabimas 1
Cabo Frio 1
Casablanca 1
Charleston 1
Columbus 1
Corpus Christi 1
Corumbá 1
Council Bluffs 1
Curitiba 1
Dallas 1
Elora 1
Ercolano 1
Espoo 1
Falkenstein 1
Frankfurt am Main 1
Gujranwala 1
Haiphong 1
Hanoi 1
Hưng Yên 1
Islamabad 1
Jakarta 1
Jinan 1
João Câmara 1
Juiz de Fora 1
Juneau 1
Lappeenranta 1
Lecce 1
Maringá 1
Mirabela 1
Mirante 1
Misciano 1
Nashville 1
Osasco 1
Presidente Tancredo Neves 1
Recife 1
Riga 1
Rio de Janeiro 1
San Francisco 1
San Nicola la Strada 1
Shanghai 1
Sousa 1
Suzano 1
São Carlos 1
Tianjin 1
Venâncio Aires 1
Totale 274
Nome #
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 116
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 93
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 82
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy 65
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 56
Totale 412
Categoria #
all - tutte 1.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202346 3 0 0 1 4 7 9 1 19 0 1 1
2023/202425 2 1 2 2 7 6 0 0 0 1 0 4
2024/2025131 3 4 0 11 13 17 15 16 18 19 7 8
2025/2026210 24 33 23 15 51 64 0 0 0 0 0 0
Totale 412